PUBLISHER: Verified Market Research | PRODUCT CODE: 1628462
PUBLISHER: Verified Market Research | PRODUCT CODE: 1628462
The increasing frequency of chronic diseases such as cancer, neurological disorders, and gastrointestinal ailments is driving up demand for enteral nutrition among people who are unable to eat meals orally. Furthermore, as the population ages, the incidence of illnesses needing long-term enteral feeding rises, extending the patient base is surpassing USD 3.87 Billion in 2024 and reaching USD 5.87 Billion by 2031.
Technological improvements in enteral feeding devices, such as smart feeding pumps with integrated monitoring systems, improve patient safety and comfort, driving market expansion fuels is expected to grow at a CAGR of about 5.89% from 2024 to 2031.
Enteral Feeding Devices Market: Definition/ Overview
Enteral feeding systems are medical instruments that provide nutrients directly to the gastrointestinal tract in patients who are unable to eat orally owing to a variety of medical issues. These devices include feeding tubes, pumps, and syringes for administering liquid nourishment formulae. Common uses include use in hospitals for patients recovering from surgery, long-term care for people with chronic illnesses, and home care for patients who need continual nutritional support. The future of enteral feeding devices looks optimistic, thanks to technological breakthroughs like smart feeding pumps and integrated monitoring systems that improve safety and efficiency. Furthermore, increased awareness of the importance of nutrition in patient recovery and treatment is predicted to expand the market further, as well as there is a rising need for home healthcare solutions and individualized nutrition.
The popularity of smart enteral feeding pumps is rapidly increasing, owing to technology improvements and growing healthcare digitization. According to in February 2024 study by the American Society for Parenteral and Enteral Nutrition (ASPEN), smart feeding pump utilization in hospitals increased by 45% over 2022, with 78% of U.S. hospitals now using connected enteral feeding systems. The Healthcare Information and Management Systems Society (HIMSS) revealed in March 2024 that smart pump-related medical errors decreased by 68% in facilities using intelligent feeding devices, while the Centers for Medicare & Medicaid Services (CMS) reported that healthcare facilities using smart pumps saved an average of $375,000 per year due to reduced complications and improved efficiency.
In January 2024,Medtronic announced a $600 million investment in its smart pump division, following a 32% year-over-year sales increase in its enteral feeding segment. In March 2024Fresenius Kabi debuted their next-generation smart enteral feeding system, with a 40% rise in smart pump installations in North America. In 2023, the FDA authorized 12 new smart feeding devices, setting a record for innovation in this area. In February 2024 Additionally, Cardinal Health claimed that their smart pump sales increased by 55% over the previous year, while B. Braun announced a $300 million expansion of their smart pump manufacturing facility in December 2023. The UK's National Health Service (NHS) also announced in March 2024 a £250 million program to renovate all hospitals.
Increasing infections and tube displacement are major issues that could stymie the expansion of the enteral feeding systems industry. Enteral feeding infections, such as tube-related infections and gastrointestinal problems, pose substantial risks to patients' safety. These issues can result in longer hospital stays, higher healthcare expenses, and a greater demand on healthcare providers. As a result, hospitals and clinics may be more cautious about adopting these devices, potentially slowing market growth. Furthermore, difficulties from poor installation or displacement of feeding tubes might result in insufficient nutrition delivery, compromising patient health and recovery.
Furthermore, the presence of these diseases may increase the demand for healthcare professional training and education, thus raising operational expenses for healthcare facilities. The requirement for more stringent monitoring and maintenance protocols to ensure patient safety may also undermine the efficiency and convenience that enteral feeding devices seek to deliver. This climate can create barriers to widespread acceptance and encourage manufacturers to invest more in developing safer, more reliable technology, thereby delaying market expansion.
The increasing demand for enteral feeding pumps is projected to drive the enteral feeding device market. Enteral feeding pumps enable precise control over nutrient delivery, improving patient safety and enabling for personalized feeding programs that fit individual nutritional requirements. As healthcare facilities recognize the value of personalized nutrition, particularly for patients with chronic conditions, the use of these pumps is expected to increase. For instance, in June 2024, Abbott announced the release of their new enteral feeding pump, which incorporates modern technology that enhances accuracy and convenience of use for healthcare providers, contributing to the trend toward more effective enteral nutrition management.
Furthermore, the transition to home healthcare and outpatient settings is increasing the demand for portable and user-friendly enteral feeding pumps. Patients and caregivers prefer user-friendly gadgets that enable at-home nutrition management. In September 2024, Fresenius Kabi unveiled a new line of tiny enteral feeding pumps developed exclusively for home use, demonstrating the market's response to consumer demand. This trend not only improves patient quality of life, but it also motivates healthcare systems to invest in enteral feeding technology, which will drive market growth as more providers and patients adopt these new solutions.
The enteral feeding tubes segment is the fastest expanding, owing to an increase in the number of patients requiring long-term nutritional support, particularly in home care settings. Advances in tube materials and designs that increase comfort and lower the risk of problems are driving this growth, as more healthcare practitioners and patients discover the benefits of enteral nourishment.
The increasing use of enteral feeding devices in oncology is projected to fuel significant growth in the enteral feeding devices market. Cancer therapies, such as chemotherapy and radiation therapy, frequently cause symptoms such as nausea, trouble swallowing, and loss of appetite, demanding different feeding options for patients. As a result, healthcare providers are increasingly turning to enteral feeding options to guarantee that patients get enough nutrition during their therapy. For instance, in March 2024, Nutricia, introduced a new enteral nutrition formula designed specifically for cancer patients, demonstrating the growing demand for customized nutritional support in the oncology industry.
Furthermore, the emphasis on improving patient outcomes in oncology care is encouraging healthcare facilities to use enteral feeding systems more widely. The incorporation of these devices into oncology care regimens not only aids in nutritional maintenance, but also promotes recovery and improves overall quality of life for patients receiving treatment. In April 2024, B. Braun announced a collaboration with a prominent cancer treatment facility to supply enteral feeding pumps and healthcare professional training, demonstrating the company's commitment to improve nutritional support for cancer patients. This trend is expected to intensify as awareness of the relevance of enteral nutrition in oncology grows, resulting in market expansion in this area.
The neurology category is the fastest expanding, owing to an increase in the incidence of neurological conditions such as stroke and neurodegenerative diseases, both of which usually demand long-term enteral feeding. As awareness of the need of nutrition in controlling these illnesses grows, along with advances in enteral feeding technology, the market for neurology devices is projected to skyrocket in the coming years.
Country/Region-wise
The increasing frequency of chronic diseases is expected to greatly boost the enteral feeding device market. Chronic ailments such as cancer, neurological disorders, and gastrointestinal diseases can cause malnutrition due to difficulty with oral intake. According to the World Health Organization (WHO), chronic diseases are expected to account for 73% of all deaths worldwide by 2025, highlighting the growing need for efficient nutritional assistance via enteral feeding. In this context, enteral feeding devices are critical options for maintaining patient nutrition and improving recovery, hence generating market demand.
In February 2024, Medtronic stated that it would expand its enteral feeding product portfolio to include new feeding tubes and pumps intended exclusively for patients with chronic diseases. This development is consistent with the growing need for nutritional interventions in the management of chronic diseases, as healthcare providers strive to improve patient outcomes. According to Verified Market Research reported that the global enteral feeding devices market is estimated to reach $5.87 billion by 2031, growing at a CAGR of 5.89%, highlighting the critical demand for these devices in view of the rising chronic disease burden.
The increasing awareness of the necessity of nutritional support for a variety of health issues in Asia Pacific is likely to drive the enteral feeding devices market. As healthcare professionals and caregivers appreciate the need of proper nutrition in patient recovery and chronic illness management, the demand for enteral feeding solutions is expanding. According to the World Health Organization, malnutrition affects around half of hospitalized patients, particularly those with chronic illnesses, underlining the critical need for appropriate nutritional therapies. This increased awareness is leading to more integrated approaches to patient care, with enteral feeding becoming standard practice in treatment protocols.
In March 2024 Abbott stated that it would expand its enteral feeding product portfolio in Asia Pacific, releasing new formulas and feeding systems based on local nutritional requirements. This step is intended to address the growing demand for specialist nutritional support in nations with high rates of malnutrition and chronic illnesses. Owing to increasing awareness and implementation of enteral nutrition methods throughout the region's healthcare systems. As the importance of nutrition grows, the industry is expected to expand significantly, with backing from both healthcare providers and patient advocacy.
The competitive landscape of the enteral feeding devices market is characterized by a mix of established companies and emerging players, each vying for market share through innovation and strategic collaborations. Key trends include the development of advanced feeding pumps with smart technology features, which enhance patient safety and improve the efficiency of feeding processes. Additionally, manufacturers are focusing on expanding their product portfolios to cater to diverse patient needs, including specialized formulas and delivery systems. The market is also witnessing an increase in partnerships between healthcare providers and device manufacturers to enhance product accessibility and education for healthcare professionals.
Some of the prominent players operating in the enteral feeding devices market include:
Braun Melsungen Ag
Boston Scientific
CONMED Corporation
Becton
Dickinson and Company
Fresenius Kabi
Nestle S.A.
Danone
Cardinal Health, Inc.
Moog, Inc.,
Cook Medical
Halyard Surgical
In May 2024, Geratherm Medical introduced a new portable enteral feeding device for home care settings. This innovation intends to improve the quality of life for patients who require long-term nutritional support at home by making enteral feeding more accessible and convenient.
In June 2024, Nutricia announced a new line of enteral feeding solutions for juvenile patients. This discovery meets the specific nutritional demands of youngsters with varied medical conditions, broadening their range and appealing to a vital part of the market.